Rosetta Genomics Stock Price Patterns
| ROSGQ Stock | USD 0.0002 0.00 0.00% |
Momentum 100
Buy Peaked
Oversold | Overbought |
Using Rosetta Genomics hype-based prediction, you can estimate the value of Rosetta Genomics from the perspective of Rosetta Genomics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Rosetta Genomics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Rosetta because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Rosetta Genomics after-hype prediction price | USD 1.24E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Rosetta |
Rosetta Genomics After-Hype Price Density Analysis
As far as predicting the price of Rosetta Genomics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Rosetta Genomics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Rosetta Genomics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Rosetta Genomics Estimiated After-Hype Price Volatility
In the context of predicting Rosetta Genomics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Rosetta Genomics' historical news coverage. Rosetta Genomics' after-hype downside and upside margins for the prediction period are 0.00 and 12.80, respectively. We have considered Rosetta Genomics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Rosetta Genomics is out of control at this time. Analysis and calculation of next after-hype price of Rosetta Genomics is based on 3 months time horizon.
Rosetta Genomics Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Rosetta Genomics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Rosetta Genomics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Rosetta Genomics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.64 | 12.80 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0002 | 0.0001 | 37.88 |
|
Rosetta Genomics Hype Timeline
Rosetta Genomics is at this time traded for 0.0002. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Rosetta is forecasted to decline in value after the next headline, with the price expected to drop to 1.24E-4. The average volatility of media hype impact on the company price is insignificant. The price reduction on the next news is expected to be -37.88%, whereas the daily expected return is at this time at 1.64%. The volatility of related hype on Rosetta Genomics is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has price-to-book ratio of 0.01. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Rosetta Genomics recorded a loss per share of 6.41. The entity last dividend was issued on the 17th of March 2017. The firm had 1:12 split on the 17th of March 2017. Assuming the 90 days horizon the next forecasted press release will be within a week. Check out Rosetta Genomics Basic Forecasting Models to cross-verify your projections.Rosetta Genomics Related Hype Analysis
Having access to credible news sources related to Rosetta Genomics' direct competition is more important than ever and may enhance your ability to predict Rosetta Genomics' future price movements. Getting to know how Rosetta Genomics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Rosetta Genomics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ONCSQ | OncoSec Medical Incorporated | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MTST | MetaStat | 0.00 | 1 per month | 0.00 | 0.11 | 0.00 | 0.00 | 147.62 | |
| MOTS | Motus GI Holdings | 0.00 | 0 per month | 0.00 | (0) | 0.00 | 0.00 | 150.00 | |
| LGBI | Cannabiz Mobile | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BIOCQ | Biocept | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 1,995 | |
| HRAL | Hear Atlast Holdings | 0.00 | 0 per month | 6.32 | 0 | 25.00 | (20.00) | 45.00 | |
| SIGO | Sunset Island Group | 0.00 | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ATRX | Adhera Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PJET | Priority Aviation | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Rosetta Genomics Additional Predictive Modules
Most predictive techniques to examine Rosetta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Rosetta using various technical indicators. When you analyze Rosetta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Rosetta Genomics Predictive Indicators
The successful prediction of Rosetta Genomics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Rosetta Genomics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Rosetta Genomics based on analysis of Rosetta Genomics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Rosetta Genomics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Rosetta Genomics's related companies.
Pair Trading with Rosetta Genomics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Rosetta Genomics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rosetta Genomics will appreciate offsetting losses from the drop in the long position's value.Moving against Rosetta Pink Sheet
| 0.8 | HPQ | HP Inc | PairCorr |
| 0.48 | PTAIF | PT Astra International | PairCorr |
| 0.32 | TRV | The Travelers Companies | PairCorr |
The ability to find closely correlated positions to Rosetta Genomics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Rosetta Genomics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Rosetta Genomics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Rosetta Genomics to buy it.
The correlation of Rosetta Genomics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rosetta Genomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rosetta Genomics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Rosetta Genomics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Rosetta Pink Sheet Analysis
When running Rosetta Genomics' price analysis, check to measure Rosetta Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rosetta Genomics is operating at the current time. Most of Rosetta Genomics' value examination focuses on studying past and present price action to predict the probability of Rosetta Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rosetta Genomics' price. Additionally, you may evaluate how the addition of Rosetta Genomics to your portfolios can decrease your overall portfolio volatility.